Company intelligence / Profile preview

Perlegen Sciences

Venice, Florida, United States

Ownership: Private
Employees: ~17
Development stage: Other

Overview

Perlegen Sciences was a biotechnology company focused on genetic research that operated from late 2000 until October 30, 2009. Founded by David R. Cox, the company's core mission was to identify patterns of genetic variation between individuals and use this information to improve patient care and uncover the genetic foundations of diseases. Perlegen developed and deployed high-density whole-wafer microarray technology in combination with novel sample preparation approaches to scan entire human genomes. The company actively participated in the International HapMap Project.

Industry: Molecular Diagnostics

Partnerships

International HapMap Project

Beyond the preview

Go deeper on Perlegen Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Perlegen Sciences.

Explore the full profile